Professor Thomas Oxley MBBS BMedSc FRACP PhD is a vascular and interventional neurologist and world expert in brain computer interfaces. Dr Oxley is the founding CEO of Synchron.
He is a Clinical Instructor, Attending in the Department of Neurosurgery, Mount Sinai Hospital, New York City. Dr Oxley has performed over 1600 endovascular neurosurgical procedures, including cerebral aneurysm coiling and clot retrievals in acute stroke. Dr Oxley has published over 120 internationally peer reviewed articles in journals including JAMA Neurology, Nature Biotechnology, Nature Biomedical Engineering, New England Journal of Medicine and The Lancet. He has over 100 patents filed. He is also Professor of Medicine, University of Melbourne, Australia.
In 2023, Dr Oxley and Synchron completed enrollment in an FDA-approved clinical trial on the Stentrode motor neuroprosthesis that is paving the way towards first FDA marketing approval for an implanted brain computer interface, bringing the total number of patients implanted with the system to 10 worldwide.
Neurological conditions are the leading global cause of disability, affecting more than three billion people worldwide. Combined with mental health conditions and substance use disorders,...
Chronic neurological conditions, such as paralysis, Alzheimer's and Parkinson's disease, affect millions globally and impact individuals, families and healthcare systems. Despite signific...
